{"id":"NCT01445301","sponsor":"GlaxoSmithKline","briefTitle":"Study STF115287, a Clinical Confirmation Study of GSK2585823 in the Treatment of Acne Vulgaris in Japanese Subjects","officialTitle":"Study STF115287, a Clinical Confirmation Study of GSK2585823 (Clindamycin 1%-Benzoyl Peroxide 3% Gel) in the Treatment of Acne Vulgaris in Japanese Subjects. - A Multicenter, Randomized, Single-blind, Active-controlled, Parallel-group Study -","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-09-27","primaryCompletion":"2012-08-02","completion":"2012-08-02","firstPosted":"2011-10-03","resultsPosted":"2018-04-27","lastUpdate":"2018-04-27"},"enrollment":800,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Acne Vulgaris"],"interventions":[{"type":"DRUG","name":"GSK2585823(CLDM 1%-BPO 3% gel)","otherNames":["GSK2585823"]},{"type":"DRUG","name":"CLDM 1% gel twice daily","otherNames":["CLDM"]}],"arms":[{"label":"GSK2585823(CLDM 1%-BPO 3% gel) once daily","type":"EXPERIMENTAL"},{"label":"GSK2585823(CLDM 1%-BPO 3% gel) twice daily","type":"EXPERIMENTAL"},{"label":"CLDM 1% gel twice daily","type":"ACTIVE_COMPARATOR"}],"summary":"This is a multicenter, randomized, single-blinded (investigator's blinded), active-controlled (clindamycin \\[CLDM\\] 1% gel), parallel-group study in Japanese subjects with acne vulgaris to demonstrate the efficacy of GSK2585823 (CLDM 1%-benzoyl peroxide \\[BPO\\] 3% gel) when applied once or twice daily for 12 weeks. This study will also evaluate the safety of GSK2585823 when applied topically either once or twice daily for 12 weeks.","primaryOutcome":{"measure":"Absolute Change From Baseline to Week 12 in Total Lesion Counts.","timeFrame":"Baseline (Day 1) and Week 12","effectByArm":[{"arm":"GSK2585823 Once Daily","deltaMin":-57.2,"sd":1.94},{"arm":"GSK2585823 Twice Daily","deltaMin":-60.8,"sd":1.53},{"arm":"CLDM Twice Daily","deltaMin":-49.8,"sd":1.52}],"pValues":[{"comp":"OG001 vs OG002","p":"<0.001"},{"comp":"OG000 vs OG002","p":"<0.001"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":16},"locations":{"siteCount":26,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":204},"commonTop":["Nasopharyngitis","Dry skin","Dermatitis contact","Erythema","Pruritus"]}}